Cash Position
The company is cashflow positive based on quarterly cash flow of 0.00
Commentary on Financial Condition
The company has recently completed a business combination with OSR Co., Ltd., and has been actively extending deadlines to consummate this business combination, indicating a focus on securing its operational future. Despite this, the company faces liquidity challenges, with a working capital deficit of $6,263,411 as of December 31, 2024, and substantial doubt about its ability to continue as a going concern. The company has sought additional capital through a PIPE investment, which was canceled, and is now pursuing a common stock purchase agreement with White Lion GBM Innovation Fund to raise up to $80,000,000. The company has no long-term debt but has deferred underwriting and legal fees payable upon the consummation of its business combination., Filed At: 2025-04-22
Former Symbols
BLACOSRH
Nasdaq Compliance
Date
Deficiency
Market
Status
Notes
Feb 15, 2024
Shareholders
NCM
OPEN
Bellevue Life Sciences Acquisition Corp. received a second notice from Nasdaq regarding non-compliance with the minimum public holders requirement, with a deadline to demonstrate compliance by February 17, 2025. The Nasdaq Hearings Panel granted continued listing contingent upon meeting this requirement, and the company must notify Nasdaq of any significant events affecting compliance during the exception period. Filed At: 2024-10-10.
Previous Splits
Date
Split
Convertibles
Title | Registered | Shares Remaining | Cv Price | $ Amt Remaining | Total $ Amt | Owners | Bank | Price Protection | Details | Convertible Date | Maturity Date | Filed Date | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Convertible Note with White Lion Capital | Not Registered | 1,110,000 | $1.00 | $1,110,000.00 | $1,110,000.00 | White Lion Capital, LLC | Variable Rate, Full Ratchet | Convertible at 95% of the lowest VWAP fifteen days prior to the conversion notice. Additionally, there is a "Default Conversion Price" which is set at $0.01 per share, applicable under certain conditions such as an Event of Default. The conversion price is subject to adjustments for stock splits, stock dividends, rights offerings, and other similar events. It can also be affected by a "Dilutive Issuance," where the conversion price is reduced to the amount of the consideration per share received by the borrower in such an issuance. | - | Feb 6, 2026 | May 12, 2025 | ||
October 2024 - Convertible Promissory Note | Not Registered | 98,765 | $8.10 | $800,000.00 | $800,000.00 | Duksung Co., LTD. | - | - | Oct 22, 2024 | ||||
October 2024 - Series A Preferred Stock Convertible | Not Registered | 2,222,222 | $9.00 | $20,000,000.00 | $20,000,000.00 | Toonon Partners Co., Ltd. | - | - | Oct 10, 2024 |
Completed Offerings
Title | Offering Amt | Shr Amt | Share Price | Warrants | Bank | Owners | Date | Type | |
|---|---|---|---|---|---|---|---|---|---|
PIPE INVESTMENT AMENDMENT | $20.00 M | 222.22 k | $90.00 | - | - | - | Dec 23, 2024 | 8-K | |
DEBT OFFERING | $300.00 k | - | - | - | - | - | Oct 28, 2024 | 8-K | |
DEBT OFFERING | $800.00 k | - | - | - | - | - | Oct 22, 2024 | 8-K | |
DEBT OFFERING | $40.00 k | - | - | - | - | - | Oct 15, 2024 | 8-K | |
PRIVATE PLACEMENT | $20.00 M | 222.22 k | - | - | N/A | - | Oct 10, 2024 | 8-K | |
IPO | $60.00 M | 6.00 M | $10.00 | 6.00 M | Chardan Capital Markets, LLC | N/A | Feb 13, 2023 | 424B4 |